1-methyl-3-isobutylxanthine has been researched along with Neurodegenerative Diseases in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eftekhari, E | 1 |
| Ghollasi, M | 1 |
| Halabian, R | 1 |
| Soltanyzadeh, M | 1 |
| Enderami, SE | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Nisin and non-essential amino acids: new perspective in differentiation of neural progenitors from human-induced pluripotent stem cells in vitro.
Topics: 1-Methyl-3-isobutylxanthine; Amino Acids; Cell Differentiation; Cell- and Tissue-Based Therapy; Cell | 2021 |